FDA Announces Withdrawal Of Unapproved Suppository Drugs For Nausea/Vomiting
This article was originally published in The Pink Sheet Daily
Agency also is revoking NDA approval of King’s Tigan trimethobenzamide suppositories.
You may also be interested in...
FDA warns eight manufacturers and 12 distributors to stop marketing unapproved drugs that contain ergotamine tartrate.
FDA is focusing initially on drugs containing the antihistamine carbinoxamine because of safety concerns in children.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.